We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 1,000 | 07:30:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
TIDMNSCI
RNS Number : 0751I
NetScientific PLC
31 March 2020
NetScientific plc
("NetScientific" or the "Company")
Board Changes
London, UK - 31 March 2020 - NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, today announces planned changes to its Board of Directors.
Sir Richard Sykes will retire from the Board following nine years as Chairman. John Clarkson, currently a Non-Executive Director of the Company, will take over as the Chairman of the Board with immediate effect.
In addition, Ian Postlethwaite will retire from the Board and step down as CEO/CFO and Company Secretary following four years at Netscientific during April 2020.
It is expected that Dr. Ilian Iliev, currently a Non-Executive Director, will become a part time Executive Director and interim CEO once terms have been agreed. A further announcement will be made at this point.
Finally, it is anticipated that Stephen Crowe, currently Financial Controller, will take over as interim CFO during April 2020 once terms have been agreed.
John Clarkson, Chairman of NetScientific, said : "We would like to thank Sir Richard and Ian for their significant contributions to the Company. Sir Richard has provided great strategic insight and direction during his time on the Board as Chairman and we wish him well in the future. The Board would also like to put on record its gratitude to Ian for his commitment and leadership of Netscientific since joining in 2016, during a very challenging period and wishes him every success in his future interests."
# # #
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Following the publication of this announcement, this inside information is now considered to be in the public domain.
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800 Ian Postlethwaite, CEO/CFO WHIreland (NOMAD, Financial Adviser Tel: +44 (0)20 7220 1666 and Broker) Chris Fielding / Darshan Patel MO PR ADVISORY (Press Contact) Tel: +44 (0)78 7644 4977 Mo Noonan
About NetScientific
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
For more information, please visit the website at www.NetScientific.net
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAJMMBTMTIJBFM
(END) Dow Jones Newswires
March 31, 2020 02:00 ET (06:00 GMT)
1 Year Netscientific Chart |
1 Month Netscientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions